These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19660587)

  • 21. Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies.
    Peng X; Ye X; Wang S
    Vaccine; 2004 Jul; 22(21-22):2750-6. PubMed ID: 15246607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 35 kDa antigenic protein from Shigella flexneri: in silico structural and functional studies.
    Yung-Hung RL; Ismail A; Lim TS; Choong YS
    Biochem Biophys Res Commun; 2011 Nov; 415(2):229-34. PubMed ID: 21982766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.
    Pore D; Mahata N; Pal A; Chakrabarti MK
    PLoS One; 2011; 6(7):e22663. PubMed ID: 21818362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine potential for inactivated shigellae.
    Osorio M; Bray MD; Walker RI
    Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region.
    Kortekaas J; Pettersson A; van der Biezen J; Weynants VE; van der Ley P; Poolman J; Bos MP; Tommassen J
    Vaccine; 2007 Jan; 25(1):72-84. PubMed ID: 16914236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabbit antisera against three different bacteria which can induce reactive arthritis: analysis by ELISA, immunoprecipitation and Western Blot.
    Ogasawara M; Kobayashi S; Hill JL; Kono DH; Yu DT
    Immunology; 1985 Apr; 54(4):665-76. PubMed ID: 3884493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Approach to Identify and Characterize a Subunit Candidate Shigella Vaccine Antigen.
    Pore D; Chakrabarti MK
    Methods Mol Biol; 2016; 1403():433-44. PubMed ID: 27076146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural optimisation of a conformational epitope improves antigenicity when expressed as a recombinant fusion protein.
    Georgousakis MM; Hofmann A; Batzloff MR; McMillan DJ; Sriprakash KS
    Vaccine; 2009 Nov; 27(48):6799-806. PubMed ID: 19729086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a.
    Turbyfill KR; Joseph SW; Oaks EV
    Infect Immun; 1995 Oct; 63(10):3927-35. PubMed ID: 7558301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reaction of the hematopoietic system in mice to the administration of virulent and avirulent strains of Shigella flexneri 2A].
    Nikolaeva TN; Sanin AV; Belaia IuA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1987; (6):17-22. PubMed ID: 3304434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some biological properties of outer membrane proteins of Shigella.
    Witkowska D; Czarny A; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):759-62. PubMed ID: 3334007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
    Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
    Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a.
    Theillet FX; Saul FA; Vulliez-Le Normand B; Hoos S; Felici F; Weintraub A; Mulard LA; Phalipon A; Delepierre M; Bentley GA
    J Mol Biol; 2009 May; 388(4):839-50. PubMed ID: 19328810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B.
    Oaks EV; Turbyfill KR
    Infect Immun; 1992 Feb; 60(2):557-64. PubMed ID: 1370431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1.
    Roy S; Das AB; Ghosh AN; Biswas T
    Infect Immun; 1994 Oct; 62(10):4333-8. PubMed ID: 7927692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of the outer membrane proteins, determined by the Shigella flexneri invasiveness plasmid, in inducing cellular immune reactions].
    Nikolaeva TN; Bondarenko VM; Nastichkin IA; Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):33-6. PubMed ID: 7778372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive proteomic analysis of Shigella flexneri 2a membrane proteins.
    Wei C; Yang J; Zhu J; Zhang X; Leng W; Wang J; Xue Y; Sun L; Li W; Wang J; Jin Q
    J Proteome Res; 2006 Aug; 5(8):1860-5. PubMed ID: 16889407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activity.
    Jarząb A; Witkowska D; Ziomek E; Dąbrowska A; Szewczuk Z; Gamian A
    PLoS One; 2013; 8(8):e70539. PubMed ID: 23940590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.